These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1139 related articles for article (PubMed ID: 35422048)
1. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma. Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048 [TBL] [Abstract][Full Text] [Related]
2. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients. Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038 [TBL] [Abstract][Full Text] [Related]
3. A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma. Chen S; Zhang E; Guo T; Shao J; Wang T; Zhang N; Wang X; Zheng J BMC Cancer; 2022 Jan; 22(1):1. PubMed ID: 34979993 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma. Zheng B; Niu Z; Si S; Zhao G; Wang J; Yao Z; Cheng F; He W Aging (Albany NY); 2021 Aug; 13(15):19789-19804. PubMed ID: 34370716 [TBL] [Abstract][Full Text] [Related]
5. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma. Hong Y; Lin M; Ou D; Huang Z; Shen P BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531 [TBL] [Abstract][Full Text] [Related]
6. A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma. Wu G; Wang Q; Xu Y; Li Q; Cheng L Aging (Albany NY); 2020 Jul; 12(14):14933-14948. PubMed ID: 32688345 [TBL] [Abstract][Full Text] [Related]
7. Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma. Liu S; Yao Y; Hou M; Mei J; Sun L; Zhang G BMC Cancer; 2023 Nov; 23(1):1079. PubMed ID: 37940859 [TBL] [Abstract][Full Text] [Related]
8. Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model. Xiang X; Guo Y; Chen Z; Zhang F; Qin Y Cancer Biomark; 2023; 37(2):95-107. PubMed ID: 37248883 [TBL] [Abstract][Full Text] [Related]
9. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma. Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma. Pang S; Zhao S; Dongye Y; Fan Y; Liu J Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906 [TBL] [Abstract][Full Text] [Related]
11. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma. Zhao E; Bai X Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes. Diao X; Guo C; Liu L; Wang G; Li S Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma. Ju L; Shi Y; Liu G PeerJ; 2022; 10():e14506. PubMed ID: 36570012 [TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma. Zhu Z; Zhang C; Qian J; Feng N; Zhu W; Wang Y; Gong Y; Li X; Lin J; Zhou L Cancer Cell Int; 2022 Sep; 22(1):283. PubMed ID: 36104748 [TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients. Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753 [TBL] [Abstract][Full Text] [Related]
16. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma. Liu JW; Supandi F; Dhillon SK Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853 [TBL] [Abstract][Full Text] [Related]
18. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma. He Z; Deng T; Duan X; Zeng G Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma. Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670 [TBL] [Abstract][Full Text] [Related]
20. A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma. Chen J; Zhan Y; Zhang R; Chen B; Huang J; Li C; Zhang W; Wang Y; Gao Y; Zheng J; Li Y Front Oncol; 2021; 11():700084. PubMed ID: 34249761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]